Repurposed Antidepressant Shows Early Promise in COVID-19
The antidepressant fluvoxamine may help prevent serious respiratory problems when administered early in the course of COVID-19, results of a randomized, placebo-controlled trial show.
The antidepressant fluvoxamine may help prevent serious respiratory problems when administered early in the course of COVID-19, results of a randomized, placebo-controlled trial show.
Covering an overview of the condition, differential diagnoses, advice for those with the condition, and treatment
Do you know how to integrate the current evidence about Janus kinase (JAK) inhibitors?
This updated summary covers the diagnosis, management, and referral of people with earwax impaction
For Black Americans, racial discrimination in midlife is associated with an increased risk of developing Alzheimer’s disease later in life, new findings show.
Dr Keppler-Noreuil discusses PIK3CA-related overgrowth spectrum main clinical features and management.
A summary of NICE guidance on assessing and treating diarrhoea in adults, with recommendations on assessment, dehydration, and referral
Measles resurgence threatens global health, with rising cases and travel-related risks. Experts discuss the outbreak’s impact on healthcare.
A retrospective review that may be the first to examine the topic found differences in mpox symptoms between White non-Hispanic patients and patients of color.
Study finds slightly higher risk in children at 10 years, but experts say this shouldn’t change current supplementation recommendations.
A study in a primarily Hispanic population points to the need for improved communication between patients and providers.